skip to content
   

 

 

Leading Independent Research and Consulting Company Focused on Peripheral Artery Disease (PAD)
and Critical Limb Ischemia (CLI)


Consulting Expertise

 

Diseases

 

Therapies

 

Economics

 

Knowledge & Awareness

Peripheral Artery Disease
PAD

Chronic Total Occlusions

Macro Costs

Physician

Critical Limb Ischemia
CLI

Thrombus Removal
Thrombolytics

Cost-Effectiveness

Consumer

Intermittent Claudication
IC

Anticoagulants

Outcomes

 

Asymptomatic Disease

Antiplatelets

Competitive Product Analysis

 

Acute Limb Ischemia
ALI

Balloon Angioplasty

Technology Assessment

 

Diabetic Foot Ulcer DFU

Atherectomy

Coding

 

Peripheral Neuropathy

Stents

Reimbursement

 

Buerger’s Disease

Peripheral Bypass

 

 

 

Angiogenesis/Biotechnology

 

 

 

Stem Cells

 

 

 

GEOGRAPHIC EXPERTISE

United States

Europe

Canada

Middle East

Latin America

China

India

Asia

 

 

PRICING & SAMPLE PROJECTS
PROPRIETARY RESEARCH DATABASES

THE SAGE GROUP Research:

The prevalence of peripheral artery disease (PAD) in the U.S. is much higher than the commonly cited figures of 8-12 million.

According to THE SAGE GROUP, 20 million people in the U.S. had PAD in 2015.

 

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development